|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||520.021 g/mol g·mol−1|
|3D model (JSmol)|
Lecozotan is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients. As of June 2008[update], the first Phase III clinical trial has been completed.
|AChE inhibitor medications|
|Experimental BACE inhibitors|
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|